Whole blood to treat adults with severe bleeding trauma
Part of Injuries & trauma clinical trials.
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years).
- You were brought in with major trauma and severe bleeding shock, and your hospital has activated a trauma code.
- Doctors decide you may need a massive transfusion (for example, ABC score 2 or higher, or the treating team thinks it’s likely).
- Whole blood (or blood component therapy) is available at the hospital at the time of treatment.
- You arrive and start study steps within about 4 hours from injury to hospital, and within about 2 hours from hospital arrival to randomization.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving whole blood (instead of separate blood parts) to adults with major traumatic bleeding in the prehospital setting improves survival. It's for patients who need blood immediately after a serious injury.
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
This trial tests whether giving norepinephrine early helps adults with severe bleeding from injury. It is for patients who have lost a lot of blood or show signs of shock.
This trial tests whether giving calcium and vasopressin early can improve outcomes in people with major injury who are at risk for life-threatening bleeding shock. It mainly includes patients who need rapid blood transfusion and likely major surgery to stop bleeding.
This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.
This trial tests whether giving calcium during massive blood transfusions helps trauma patients with severe bleeding. It may improve survival and recovery.
Hear when a new Trauma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.